[
    [
        {
            "time": "2021-05-10",
            "original_text": "业内：市场对药明康德解禁已有充分预期 影响并不大 解禁",
            "features": {
                "keywords": [
                    "药明康德",
                    "解禁",
                    "市场预期"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "业内：市场对药明康德解禁已有充分预期 影响并不大 解禁",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "药明康德(603259)2021年一季报点评：季度收入环比迭创新高 投资收益影响下利润实现超高增长",
            "features": {
                "keywords": [
                    "药明康德",
                    "一季报",
                    "收入增长",
                    "利润增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259)2021年一季报点评：季度收入环比迭创新高 投资收益影响下利润实现超高增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "不惧药明康德900亿解禁市值，刘彦春一季度逆势加仓！ 解禁",
            "features": {
                "keywords": [
                    "药明康德",
                    "解禁",
                    "刘彦春",
                    "加仓"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "不惧药明康德900亿解禁市值，刘彦春一季度逆势加仓！ 解禁",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "一季度投资净赚十亿，药明康德非典型模式扩张，能否“投”出个未来？",
            "features": {
                "keywords": [
                    "药明康德",
                    "投资收益",
                    "扩张模式"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度投资净赚十亿，药明康德非典型模式扩张，能否“投”出个未来？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "粤开医药行业周报：国药新冠疫苗纳入WHO紧急使用清单 第五批国采药品信息收集工作即将开始",
            "features": {
                "keywords": [
                    "国药",
                    "新冠疫苗",
                    "WHO",
                    "药品集采"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开医药行业周报：国药新冠疫苗纳入WHO紧急使用清单 第五批国采药品信息收集工作即将开始",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "策略周报：上游内需波峰Q2 下游阶段受挤压",
            "features": {
                "keywords": [
                    "上游内需",
                    "下游挤压",
                    "Q2"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合经济"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "策略周报：上游内需波峰Q2 下游阶段受挤压",
                "Correlation": 2,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "突发利空！药明康德900亿解禁，知名基金经理刚加仓",
            "features": {
                "keywords": [
                    "药明康德",
                    "解禁",
                    "利空",
                    "基金经理"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "突发利空！药明康德900亿解禁，知名基金经理刚加仓",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "超900亿！暴涨近1300%大白马巨额解禁杀到 解禁",
            "features": {
                "keywords": [
                    "药明康德",
                    "解禁",
                    "巨额"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "超900亿！暴涨近1300%大白马巨额解禁杀到 解禁",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "晨会聚焦210510重点关注通信、计算机、保险、钢铁、汽车汽配、社会服务、纺织服装、证券、医药、家电",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "医药",
                    "多行业关注"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "通信",
                    "计算机",
                    "保险",
                    "钢铁",
                    "汽车汽配",
                    "社会服务",
                    "纺织服装",
                    "证券",
                    "家电"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦210510重点关注通信、计算机、保险、钢铁、汽车汽配、社会服务、纺织服装、证券、医药、家电",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "药明康德迎900亿限售股解禁，景顺长城基金一季度刚加仓 解禁",
            "features": {
                "keywords": [
                    "药明康德",
                    "解禁",
                    "景顺长城基金",
                    "加仓"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德迎900亿限售股解禁，景顺长城基金一季度刚加仓 解禁",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]